A detailed history of Chatham Capital Group, Inc. transactions in Lemaitre Vascular Inc stock. As of the latest transaction made, Chatham Capital Group, Inc. holds 48,489 shares of LMAT stock, worth $4.75 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares
48,489
Previous 50,059 3.14%
Holding current value
$4.75 Million
Previous $4.65 Million 3.91%
% of portfolio
0.75%
Previous 0.77%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025

SELL
$85.64 - $107.97 $134,454 - $169,512
-1,570 Reduced 3.14%
48,489 $4.47 Million
Q3 2024

Oct 15, 2024

BUY
$80.3 - $92.89 $8,431 - $9,753
105 Added 0.21%
50,059 $4.65 Million
Q2 2024

Jul 15, 2024

BUY
$62.62 - $83.59 $45,399 - $60,602
725 Added 1.47%
49,954 $4.11 Million
Q1 2024

Apr 17, 2024

BUY
$54.0 - $71.06 $473,580 - $623,196
8,770 Added 21.68%
49,229 $3.27 Million
Q4 2023

Jan 19, 2024

SELL
$45.37 - $58.41 $17,875 - $23,013
-394 Reduced 0.96%
40,459 $2.3 Million
Q3 2023

Oct 25, 2023

SELL
$53.45 - $67.01 $11,010 - $13,804
-206 Reduced 0.5%
40,853 $2.23 Million
Q2 2023

Jul 13, 2023

BUY
$50.38 - $68.21 $124,186 - $168,137
2,465 Added 6.39%
41,059 $2.76 Million
Q1 2023

Apr 21, 2023

BUY
$44.73 - $51.68 $1,162 - $1,343
26 Added 0.07%
38,594 $1.99 Million
Q2 2022

Aug 02, 2022

BUY
$39.05 - $47.85 $2,147 - $2,631
55 Added 0.14%
38,568 $1.76 Million
Q1 2022

Apr 21, 2022

BUY
$40.48 - $51.5 $22,911 - $29,149
566 Added 1.49%
38,513 $1.79 Million
Q4 2021

Feb 02, 2022

BUY
$46.66 - $56.25 $2,799 - $3,375
60 Added 0.16%
37,947 $1.91 Million
Q3 2021

Oct 13, 2021

SELL
$53.09 - $60.57 $23,147 - $26,408
-436 Reduced 1.14%
37,887 $2.01 Million
Q2 2021

Jul 28, 2021

BUY
$47.74 - $63.33 $190 - $253
4 Added 0.01%
38,323 $2.34 Million
Q1 2021

Apr 29, 2021

BUY
$40.19 - $51.5 $45,896 - $58,813
1,142 Added 3.07%
38,319 $1.87 Million
Q4 2020

Jan 27, 2021

SELL
$31.44 - $41.27 $7,860 - $10,317
-250 Reduced 0.67%
37,177 $1.51 Million
Q3 2020

Oct 22, 2020

SELL
$25.73 - $33.98 $4,579 - $6,048
-178 Reduced 0.47%
37,427 $1.22 Million
Q2 2020

Jul 20, 2020

BUY
$22.88 - $30.71 $2,013 - $2,702
88 Added 0.23%
37,605 $993,000
Q1 2020

May 01, 2020

BUY
$21.03 - $38.46 $273,873 - $500,864
13,023 Added 53.17%
37,517 $935,000
Q4 2019

Jan 31, 2020

SELL
$31.27 - $36.21 $15,822 - $18,322
-506 Reduced 2.02%
24,494 $881,000
Q3 2019

Nov 08, 2019

SELL
$27.91 - $35.78 $6,419 - $8,229
-230 Reduced 0.91%
25,000 $854,000
Q2 2019

Jul 24, 2019

SELL
$25.55 - $30.79 $10,577 - $12,747
-414 Reduced 1.61%
25,230 $706,000
Q1 2019

May 09, 2019

BUY
$22.45 - $31.55 $4,130 - $5,805
184 Added 0.72%
25,644 $795,000
Q4 2018

Feb 06, 2019

BUY
$22.01 - $37.23 $560,374 - $947,875
25,460 New
25,460 $602,000

Others Institutions Holding LMAT

About LEMAITRE VASCULAR INC


  • Ticker LMAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 21,962,900
  • Market Cap $2.15B
  • Description
  • LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that tem...
More about LMAT
Track This Portfolio

Track Chatham Capital Group, Inc. Portfolio

Follow Chatham Capital Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chatham Capital Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chatham Capital Group, Inc. with notifications on news.